20 min listen
The silent misdiagnosis
FromThe BMJ Podcast
ratings:
Length:
19 minutes
Released:
Aug 27, 2013
Format:
Podcast episode
Description
This week, Al Mulley, Dartmouth Center for Health Care Delivery Science, and Tessa Richards, BMJ associate editor, discuss the silent misdiagnosis: that of patient preferences.
Removing pre-cancerous cells spotted through screening is the foremost defence against cervical cancer. However, a recent BMJ paper has shown that women who go through this have a fourfold risk of going on to develop cancer compared to women who’ve only ever had normal smears, even if they complete follow up and are given the all clear. Matejka Rebolj, postdoctoral researcher, Department of Public Health, University of Copenhagen, and Chris Meijer and Maaike Bleeker, pathologists in the Department of Pathology, VU Medical Centre, Amsterdam, discuss what could be done to mitigate the risk.
Removing pre-cancerous cells spotted through screening is the foremost defence against cervical cancer. However, a recent BMJ paper has shown that women who go through this have a fourfold risk of going on to develop cancer compared to women who’ve only ever had normal smears, even if they complete follow up and are given the all clear. Matejka Rebolj, postdoctoral researcher, Department of Public Health, University of Copenhagen, and Chris Meijer and Maaike Bleeker, pathologists in the Department of Pathology, VU Medical Centre, Amsterdam, discuss what could be done to mitigate the risk.
Released:
Aug 27, 2013
Format:
Podcast episode
Titles in the series (100)
Carotid atherosclerosis and patient participation: A clinical review this week looks at the diagnosis and treatment of carotid atherosclerosis, including when to screen and the threshold for intervention. Alun Davies, professor of vascular surgery at Imperial College London, also answers how useful o... by The BMJ Podcast